APA (7th ed.) Citation

2-s2.0-85178580254. (2024). Development and characterization of a spray-dried inhalable ternary combination for the treatment of Pseudomonas aeruginosa biofilm infection in cystic fibrosis. European Journal of Pharmaceutical Sciences, 192, . https://doi.org/10.1016/j.ejps.2023.106654

Chicago Style (17th ed.) Citation

2-s2.0-85178580254. "Development and Characterization of a Spray-dried Inhalable Ternary Combination for the Treatment of Pseudomonas Aeruginosa Biofilm Infection in Cystic Fibrosis." European Journal of Pharmaceutical Sciences 192 (2024). https://doi.org/10.1016/j.ejps.2023.106654.

MLA (8th ed.) Citation

2-s2.0-85178580254. "Development and Characterization of a Spray-dried Inhalable Ternary Combination for the Treatment of Pseudomonas Aeruginosa Biofilm Infection in Cystic Fibrosis." European Journal of Pharmaceutical Sciences, vol. 192, 2024, https://doi.org/10.1016/j.ejps.2023.106654.